Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
3.14
Nov 20 • 3:59 PM ET Dollar change-0.24 Percentage change(-7.10%)
Aftermarket Close
3.20
Aftermarket • 7:59 PM ET Dollar change+0.06 Percentage change(1.91%)
Category
US Equities - Factor & Thematic
Sponsor
Advisor Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.75%
Inverse/Leveraged
IPO
Sep 02, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-20.24%
SMA50
-27.14%
SMA200
-28.79%
Return% 1Y
5.02%
Return% 3Y
-22.25%
Return% 5Y
-37.17%
Return% 10Y
Return% SI
Flows% 1M
-4.99%
Flows% 3M
-15.07%
Flows% YTD
-12.79%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
23
AUM
557.41M
NAV/sh
52W High
7.25 -56.69%
52W Low
2.98 5.37%
Volatility
6.70% 5.82%
ATR (14)
0.23
RSI (14)
25.31
Beta
1.56
Rel Volume
2.21
Avg Volume
5.20M
Volume
11,501,088
Perf Week
-15.59%
Perf Month
-23.04%
Perf Quarter
-35.79%
Perf Half Y
-29.12%
Perf YTD
-33.47%
Perf Year
3.63%
Perf 3Y
-52.71%
Perf 5Y
-88.99%
Perf 10Y
-
Prev Close
3.38
Price
3.14
Change %
-7.10%
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.